Efficacy and risk of rituximab in type II mixed cryoglobulinemia: a significant case report

Saved in:
Bibliographic Details
Published in:Digestive and liver disease 2007-09, Vol.39, p.S134-S135
Main Authors: Massari, Marco, Catania, Alberto, Magnani, Giacomo
Format: Article
Language:English
Subjects:
Antibodies, Monoclonal - adverse effects
Antibodies, Monoclonal - therapeutic use
Antibodies, Monoclonal, Murine-Derived
Cryoglobulinemia - drug therapy
Female
Gastroenterology and Hepatology
HCV
Hepatitis C, Chronic - complications
Humans
Immunologic Factors - adverse effects
Immunologic Factors - therapeutic use
Middle Aged
Pneumonia, Bacterial - etiology
Rituximab
Syndrome
Type II mixed cryoglobulinemia
Vasculitis - drug therapy
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:
ISSN:1590-8658
1878-3562
DOI:10.1016/S1590-8658(07)80026-0